Atrophic vaginitis is typically associated with the ... She called the birth center to report that the treatment was working, she was still nursing with no decrease in milk supply, and intercourse ...

Vaginal atrophy, often referred to as atrophic vaginitis, is a condition that affects many women ... and anxiety is crucial for providing effective treatment and support. Seeking medical advice, ...

FDA approves the first treatment for KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC), offering new hope for ...

Women often seek medical care for vaginal complaints. Many times, the cause of the complaint is misdiagnosed by the woman and/or her provider. These vaginal complaints may be related to infections ...

Boehringer Ingelheim announces the start of the JADE phase II clinical study (NCT06769048), investigating the efficacy and safety of BI 1584862 as a potential first-in-class treatment for geographic ...

Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay, this time in the US. The company has received a complete response letter (CRL) from the FDA for a ...

Astellas has shored up the competitive profile of Izervay as a treatment for eye disorder geographic atrophy (GA), getting FDA approval for an extended treatment duration. The US regulator turned ...

In some cases, doctors can’t be completely sure it’s CIDP, but they may go ahead and start treatment. If the symptoms improve, that’s strong evidence it’s CIDP. Early treatment is key.

Researchers presented an exploratory analysis comparing OCT biomarkers in a Phase 1b study of ONL1204 in patients with ...

German pharmaceutical company Boehringer Ingelheim has started the JADE Phase II clinical trial to evaluate BI 1584862 as a first-in-class oral treatment for geographic atrophy (GA). Taking place ...